CONCOMITANT HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITOR THERAPY MARKEDLY REDUCES TACROLIMUS METABOLISM AND INCREASES BLOOD LEVELS
Distribution of the number of citations over years.